These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9605828)

  • 1. High death rate from neoplasms in French diabetic and non-diabetic men.
    Balkau B; Charles MA; Eschwège E
    Lancet; 1998 May; 351(9114):1512. PubMed ID: 9605828
    [No Abstract]   [Full Text] [Related]  

  • 2. [Overviews of fibrate].
    Tada N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():609-17. PubMed ID: 11347141
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative evaluation of beta-benzalbutyramide and clofibrate in the short-term treatment of hyperlipidemic patients].
    Marini U; Bargiggia A; Riboli P
    Farmaco Prat; 1981 Dec; 36(12):532-41. PubMed ID: 7319020
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hypolipemic effectiveness of using miskleron in diabetes mellitus in children and adolescents with lipodystrophies].
    Belousova LV
    Pediatriia; 1980 Jun; (6):39-41. PubMed ID: 7402836
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic of acetiromate on hyperlipidemia--comparison with clofibrate using a double-blind method].
    Nakano Y; Fukui I; Niiho S; Kuki H; Takahata J
    Nihon Rinsho; 1974 Jul; 32(7):2526-51. PubMed ID: 4612204
    [No Abstract]   [Full Text] [Related]  

  • 6. [The mechanisms of action of etophylline-clofibrate in hyperlipidemia].
    Păduraru I; Nechifor M; Dănilă G; Jercă L; Filip M; Iacobovici A; Teslaru E; Filip C; Saramet A
    Rev Med Chir Soc Med Nat Iasi; 1993; 97(1):445-9. PubMed ID: 8153471
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects on the serum lipids of bis (hydroxy-2 ethylthio) 1,10 decane (LL 1558) and clofibrate, based on 91 cases of primary hyperlipoproteinemia].
    Rouffy J
    Sem Hop Ther; 1973 Jan; 49(1):31-6. PubMed ID: 4712022
    [No Abstract]   [Full Text] [Related]  

  • 8. The clofibrate saga: a retrospective commentary.
    Oliver M
    Br J Clin Pharmacol; 2012 Dec; 74(6):907-10. PubMed ID: 22486628
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial: Lipid-lowering drugs after myocardial infarction.
    Lancet; 1975 Mar; 1(7905):501-2. PubMed ID: 46964
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of 100 cases of essential atherogenic hyperlipoproteinemia].
    Rouffy J
    Sem Hop Ther; 1975 Nov; 51(9):467-71. PubMed ID: 173023
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of pantethine on different models of experimental hyperlipidemia in rodents: a comparison with clofibrate.
    Farina R; Lovati MR; Raucci G; Sirtori CR
    Pharmacol Res Commun; 1982 Jun; 14(6):499-510. PubMed ID: 7122675
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative hypolipidaemic effectiveness of gum guggulu (Commiphora mukul) fraction 'A', ethyl-P-chlorophenoxyisobutyrate and Ciba-13437-Su.
    Malhotra SC; Ahuja MM
    Indian J Med Res; 1971 Oct; 59(10):1621-32. PubMed ID: 5159000
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diabetic nephropathy, hypothyroidism and colfibrate-induced myopathy (author's transl)].
    Rumpf KW; Quellhrost E; Scheler F
    Med Klin; 1976 Nov; 71(46):2023-7. PubMed ID: 995042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dyslipidemia in diabetes mellitus: statins treatment raises survival of patients].
    Shestakova MV
    Ter Arkh; 1999; 71(1):67-9. PubMed ID: 10097307
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical trial of C.P.I.B. (clofibrate) in treatment of diabetic hypertriglyceridemia].
    Warembourg H; Jaillard J
    Lille Med; 1968 Jan; 13(1):Suppl:5-8. PubMed ID: 5745605
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study of clofibrate. The opinion of Prof. D. Kritchevsky].
    Fabbrocini V
    Minerva Cardioangiol; 1980 Nov; 28(11):759-60. PubMed ID: 7231692
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pyridoxine para-chloro-phenoxy-isobutyrate. Analysis of hypolipidemic effects].
    Mirouze J; Orsetti A; Cartry E
    Nouv Presse Med; 1973 Dec; 2(46):3115-6. PubMed ID: 4787779
    [No Abstract]   [Full Text] [Related]  

  • 18. [Fibrates].
    Hara F; Yamazaki J
    Nihon Rinsho; 2013 Sep; 71(9):1643-8. PubMed ID: 24205728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypolipemic property and myotoxic action of clofibrate in a case of nephrotic syndrome].
    Fabre J; Denizot M; Wildi E; Micheli H; Berthoud S
    Schweiz Rundsch Med Prax; 1973 Jun; 62(23):732-7. PubMed ID: 4705828
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative studies on the reduction of lipids using clofibric acid and clofibrate in hyperlipoproteinemias].
    Schwartzkopff W; Hoffmann H; Kästner W
    Med Welt; 1975 Dec; 26(51):2308-15. PubMed ID: 177837
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.